Study of Ovarian Carcinosarcoma
Author Information
Author(s): Harris M A, Delap L M, Sengupta P S, Wilkinson P M, Welch R S, Swindell R, Shanks J H, Wilson G, Slade R J, Reynolds K, Jayson G C
Primary Institution: Christie Hospital NHS Trust
Hypothesis
What are the demographics, management, and outcomes of patients treated for carcinosarcoma of the ovary?
Conclusion
The study found that patients with no bulk residual disease post-surgery had significantly better survival rates.
Supporting Evidence
- Carcinosarcomas account for only <1-2% of all malignant ovarian tumors.
- 80% of patients presented with advanced FIGO stage III or IV disease.
- The overall median survival was 8.7 months.
Takeaway
This study looked at women with a rare type of ovarian cancer and found that those who had less leftover cancer after surgery lived longer.
Methodology
A retrospective review of 40 patients treated for carcinosarcoma over 10 years, analyzing demographics, management, and outcomes.
Potential Biases
Potential bias due to the retrospective nature of the study and the small number of cases.
Limitations
The study is limited by the small sample size and the rarity of the disease.
Participant Demographics
Patients ranged in age from 45 to 86 years, with a median age of 65.
Statistical Information
P-Value
0.045
Statistical Significance
p=0.045
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website